Top Companies and Manufacturers of Chronic Renal Disease Stage 3 Solutions

Our product uses cutting-edge technology to address the complexities of Chronic Renal Disease Stage 3, providing patients with a reliable and effective option for their healthcare needs. In addition to its innovative approach, our treatment is also backed by rigorous testing and research to ensure its safety and efficacy, We understand the challenges that individuals with Chronic Renal Disease Stage 3 face, and we are committed to delivering a solution that makes a meaningful difference in their lives. With our unwavering dedication to quality and patient care, our product represents a significant advancement in the management of this condition, Trust Sinofn (Tianjin) Pharm-Tech Co., Ltd. to provide the support and relief that patients with Chronic Renal Disease Stage 3 need and deserve

Hot Selling Product

Gummy, Where Every Bite is a Smile

Solid Drink Form, Everything is Possible

OEM Supplements material Vitamin A

Sinofn: Your Trusted Source for Premium PQQ

OEM Supplements of PKU-Foods for age from 1 to 10 with Phenylketonuria

JUJUBE extract powder | Plant based Cyclic Adenosine Monophosphate (cAMP)

How To Evaluate Chronic Renal Disease Stage 3 Factories Products Application

Chronic Renal Disease (CRD) Stage 3 poses significant health challenges, and a growing demand for effective nutritional supplements tailored for this condition presents a unique opportunity for global buyers. As a GMP-certified OEM/ODM partner specializing in private label supplements, we provide innovative solutions for businesses looking to expand their product lines in this vital sector. Our expertise in developing gummies, liquids, and powders allows us to create targeted formulations that support kidney health, catering specifically to the needs of CRD Stage 3 patients. With a low minimum order quantity (MOQ) and turnkey solutions, we make it easy for businesses to introduce high-quality products into the market. Our extensive experience in global contract manufacturing, honed since 2012, enables us to navigate the complexities of product development, regulatory compliance, and supply chain logistics. By partnering with us, you can ensure that your offerings not only meet the highest standards of quality but also resonate with consumers seeking relief and support in managing chronic renal disease. In evaluating potential products for CRD Stage 3, it’s essential to consider the formulation, efficacy, and patient acceptance. Our team is dedicated to providing you with expert guidance on ingredient selection and product optimization, ensuring that your supplements stand out in a competitive marketplace. Reach out for a quote today to explore how we can partner together in delivering impactful solutions that enhance the lives of those affected by chronic renal disease.

How To Evaluate Chronic Renal Disease Stage 3 Factories Products Application

Parameter	Value	Unit	Comments
Serum Creatinine	1.5	mg/dL	Elevated level indicating reduced kidney function
Estimated GFR	45	mL/min	Indicates stage 3 chronic kidney disease
Albumin Level	30	mg/dL	Mildly elevated; monitor for progression
Blood Pressure	130/80	mmHg	At target; important for kidney health
Total Protein Level	6.5	g/dL	Normal range; monitor closely

Evaluation of Kidney Function Tests in Stage 3 Chronic Renal Disease

This bar chart represents the average values of various kidney function tests in patients with Stage 3 Chronic Renal Disease (CRD). The tests included in this evaluation are estimated Glomerular Filtration Rate (eGFR), serum Creatinine, Urea, Electrolytes, and Hemoglobin. In this stage of CRD, the eGFR is typically reduced, indicating impaired kidney function, and is represented by an average value of 45 mL/min/1.73m². Serum Creatinine levels increase to about 1.5 mg/dL, reflecting the kidneys' reduced ability to filter waste. Urea levels, an important nitrogenous waste product, average around 30 mg/dL, showing the retention of waste in the blood. Electrolyte levels, primarily focusing on Potassium, average around 4.5 mEq/L, which is crucial for heart and muscle function. Finally, Hemoglobin levels are an important indicator of anemia often seen in chronic kidney disease, with an average of 11 g/dL. Understanding these test results can help healthcare providers assess the severity of kidney damage and make informed decisions about patient management strategies.